CSPC PHARMACEUTICAL (CVG BE) stock market data APIs
€1.0015
0(0%)
as of March 17, 2026
Try our APIs with
free plan!
CSPC PHARMACEUTICAL Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for CVG.BE.
Prev. Close
1.0015
Open
1.0015
High
1.0015
Low
1.0015
52 wk Range
0.5016-1.2081
Market Cap
11 678 M
Dividends (Yield)
0.0963
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get CSPC PHARMACEUTICAL data using free add-ons & libraries
Get CSPC PHARMACEUTICAL Fundamental Data
CSPC PHARMACEUTICAL Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
CSPC PHARMACEUTICAL News
New
Health Care Roundup: Market Talk
Find insight on Eli Lilly, Novo Nordisk, Gilead Sciences and more in the latest Market Talks covering Health Care. Continue Reading
Novo Nordisk and Eli Lilly Slash Obesity Drug Prices in China
This article first appeared on GuruFocus. Novo Nordisk (NOVO, Financials) and Eli Lilly (LLY, Financials) are reducing prices for their leading obesity treatments, Wegovy and Mounjaro, in China to st...
Novo Nordisk Cuts Wegovy Prices in China Ahead of Patent Expiration
This article first appeared on GuruFocus. Novo Nordisk A/S (NVO, Financials) cut the price of its top selling weight loss medicine Wegovy in China on Monday, expecting tougher competition from Chines...
Alphamab Oncology Announces Biparatopic HER2-targeting ADC JSKN003 Was Granted Breakthrough Therapy Designation by the FDA for the Treatment of PROC
SUZHOU, China, Dec. 20, 2025 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that the biparatopic HER2-targeting antibody-drug conjugate (ADC) JSKN003, independently developed by the...
Get CSPC PHARMACEUTICAL fresh news feed via Financial News API
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
